跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEXTAS 20 CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ ML VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
TEXTAS 20 CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ ML VIAL
Approved
THERAPEUTIC
TEXTAS 20 CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ ML VIAL
INTAS PHARMACEUTICALS LIMITED
🇸🇬 Health Sciences Authority
Approval Date
Dec 3, 2018
Approval ID
22e197d5d0c4bb15
Company
INTAS PHARMACEUTICALS LIMITED
Type
Therapeutic
Approval Details
Approval Id
22e197d5d0c4bb15
Drug Name
TEXTAS 20 CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ ML VIAL
Product Name
TEXTAS 20 CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ ML VIAL
Approval Number
SIN15588P
Approval Date
2018-12-03
Registrant
ACCORD HEALTHCARE PRIVATE LIMITED
Licence Holder
ACCORD HEALTHCARE PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01CD02
Atc Item Name
docetaxel
Pharma Manufacturer Name
ACCORD HEALTHCARE PRIVATE LIMITED
Company Detail Path
/organization/accord-healthcare-private-limited
Active Ingredients
DOCETAXEL ANHYDROUS
20 mg / mL
DOCETAXEL ANHYDROUS
20 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 3, 2018
Approval ID
22e197d5d0c4bb15
Type
Therapeutic
Back to HSA Approvals